Pavilion Capital

Portfolio · 2

KAHR Medical

Fusion Proteins for Treating Cancer and Autoimmune Diseases

2 rounds $64.5M committed Latest: 2021-06

Airobotics

Automated Drone Platform for Industrial Facilities

1 round $40.3M committed Latest: 2018-10

Investment activity

1 portfolio exit on record.

Q&A

What is Pavilion Capital's most recent notable exit?

Pavilion Capital had a notable exit in September 2021 when Airobotics, an automated drone platform, went public on the TASE.

What sectors does Pavilion Capital focus on for its portfolio companies?

Pavilion Capital's portfolio companies are concentrated in Health Tech & Life Sciences and Aerospace, Defense & HLS.

Can you name a key portfolio company in Pavilion Capital's Health Tech & Life Sciences sector?

KAHR Medical, a company developing fusion proteins for treating cancer and autoimmune diseases, is a key portfolio company for Pavilion Capital in the Health Tech & Life Sciences sector.

What is the investment range for Pavilion Capital?

Pavilion Capital's investment range is between $18M and $46.5M.

Which portfolio company of Pavilion Capital operates in the Aerospace, Defense & HLS sector?

Airobotics, an automated drone platform for industrial facilities, is a portfolio company of Pavilion Capital in the Aerospace, Defense & HLS sector.

When was Pavilion Capital's most recent investment round?

Pavilion Capital's most recent investment round occurred in June 2021.